The emerging role of epigenetic therapeutics in immuno-oncology

MJ Topper, M Vaz, KA Marrone, JR Brahmer… - Nature Reviews …, 2020 - nature.com
The past decade has seen the emergence of immunotherapy as a prime approach to cancer
treatment, revolutionizing the management of many types of cancer. Despite the promise of …

Antigen presentation in cancer—mechanisms and clinical implications for immunotherapy

K Yang, A Halima, TA Chan - Nature Reviews Clinical Oncology, 2023 - nature.com
Over the past decade, the emergence of effective immunotherapies has revolutionized the
clinical management of many types of cancers. However, long-term durable tumour control …

MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution

C Puttick, TP Jones, MM Leung, F Galvez-Cancino… - Nature Genetics, 2024 - nature.com
Disruption of the class I human leukocyte antigen (HLA) molecules has important
implications for immune evasion and tumor evolution. We developed major …

[HTML][HTML] Cancer immunotherapy: opportunities and challenges in the rapidly evolving clinical landscape

LA Emens, PA Ascierto, PK Darcy, S Demaria… - European journal of …, 2017 - Elsevier
Cancer immunotherapy is now established as a powerful way to treat cancer. The recent
clinical success of immune checkpoint blockade (antagonists of CTLA-4, PD-1 and PD-L1) …

[HTML][HTML] Deregulation of HLA-I in cancer and its central importance for immunotherapy

A Hazini, K Fisher, L Seymour - Journal for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
It is now well accepted that many tumors undergo a process of clonal selection which means
that tumor antigens arising at various stages of tumor progression are likely to be …

SeSAMe: reducing artifactual detection of DNA methylation by Infinium BeadChips in genomic deletions

W Zhou, TJ Triche Jr, PW Laird… - Nucleic acids research, 2018 - academic.oup.com
We report a new class of artifacts in DNA methylation measurements from Illumina
HumanMethylation450 and MethylationEPIC arrays. These artifacts reflect failed …

Monalizumab: inhibiting the novel immune checkpoint NKG2A

T Van Hall, P André, A Horowitz, DF Ruan… - … for immunotherapy of …, 2019 - Springer
The implementation of immune checkpoint inhibitors to the oncology clinic signified a new
era in cancer treatment. After the first indication of melanoma, an increasing list of additional …

HLA-A* 03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study

V Naranbhai, M Viard, M Dean, S Groha… - The Lancet …, 2022 - thelancet.com
Background Predictive biomarkers could allow more precise use of immune checkpoint
inhibitors (ICIs) in treating advanced cancers. Given the central role of HLA molecules in …

HIV-1 and human genetic variation

PJ McLaren, J Fellay - Nature Reviews Genetics, 2021 - nature.com
Over the past four decades, research on the natural history of HIV infection has described
how HIV wreaks havoc on human immunity and causes AIDS. HIV host genomic research …

A genomic perspective on HLA evolution

D Meyer, VR C. Aguiar, BD Bitarello, DY C. Brandt… - Immunogenetics, 2018 - Springer
Several decades of research have convincingly shown that classical human leukocyte
antigen (HLA) loci bear signatures of natural selection. Despite this conclusion, many …